A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
City of Hope Medical Center
University Health Network, Toronto
National Cancer Institute, Naples
Spanish Oncology Genito-Urinary Group
National Cancer Institute, Naples
Sun Yat-sen University
The Netherlands Cancer Institute
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Sun Yat-sen University
AIO-Studien-gGmbH
China Medical University Hospital
University of California, San Diego
Johannes Gutenberg University Mainz
National University Hospital, Singapore
The University of Texas Health Science Center, Houston
Dong-A University Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Royal Marsden NHS Foundation Trust
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University Hospital of Crete
Fudan University
Sun Yat-sen University
Pomeranian Medical University Szczecin
University of Kentucky
Providence Health & Services
Shanghai Jiao Tong University School of Medicine
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Johannes Gutenberg University Mainz
Dermatologic Cooperative Oncology Group